Us Bancorp \De\ Dexcom Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Dexcom Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 60,018 shares of DXCM stock, worth $5.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

60,018

Previous 45,505 31.89%

Holding current value

$5.3 Million

Previous $3.05 Million 53.07%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$65.68 - $81.01 $953,213 - $1.18 Million	14,513 Added 31.89%	60,018 $4.67 Million
Q3 2024 Oct 28, 2024	SELL	$64.0 - $116.06 $3.24 Million - $5.88 Million	-50,621 Reduced 52.66%	45,505 $3.05 Million
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $446,865 - $568,962	4,051 Added 4.4%	96,126 $10.9 Million
Q1 2024 May 07, 2024	SELL	$114.22 - $140.1 $392,231 - $481,103	-3,434 Reduced 3.6%	92,075 $12.8 Million
Q4 2023 Feb 09, 2024	BUY	$75.49 - $124.16 $1.43 Million - $2.36 Million	18,987 Added 24.81%	95,509 $11.9 Million
Q3 2023 Nov 03, 2023	SELL	$86.06 - $137.93 $356,460 - $571,306	-4,142 Reduced 5.13%	76,522 $7.14 Million
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $805,622 - $938,209	-7,163 Reduced 8.16%	80,664 $10.4 Million
Q1 2023 May 09, 2023	SELL	$104.0 - $122.92 $28,288 - $33,434	-272 Reduced 0.31%	87,827 $10.2 Million
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $368,303 - $531,651	-4,334 Reduced 4.69%	88,099 $9.98 Million
Q3 2022 Oct 27, 2022	SELL	$76.35 - $94.18 $351,439 - $433,510	-4,603 Reduced 4.74%	92,433 $7.45 Million
Q2 2022 Aug 01, 2022	BUY	$67.99 - $132.89 $4.82 Million - $9.43 Million	70,924 Added 271.61%	97,036 $7.23 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $8,655 - $11,978	-92 Reduced 0.35%	26,112 $13.4 Million
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $25,194 - $31,587	194 Added 0.75%	26,204 $14.1 Million
Q3 2021 Nov 10, 2021	SELL	$106.71 - $143.18 $25,717 - $34,506	-241 Reduced 0.92%	26,010 $14.2 Million
Q2 2021 Aug 05, 2021	BUY	$80.99 - $107.93 $216,567 - $288,604	2,674 Added 11.34%	26,251 $11.2 Million
Q1 2021 Apr 28, 2021	BUY	$84.79 - $104.74 $147,449 - $182,142	1,739 Added 7.96%	23,577 $8.47 Million
Q4 2020 Feb 04, 2021	BUY	$78.0 - $104.5 $68,094 - $91,228	873 Added 4.16%	21,838 $8.07 Million
Q3 2020 Nov 10, 2020	SELL	$95.51 - $112.95 $198,278 - $234,484	-2,076 Reduced 9.01%	20,965 $8.64 Million
Q2 2020 Aug 07, 2020	SELL	$62.68 - $105.34 $179,703 - $302,009	-2,867 Reduced 11.07%	23,041 $9.34 Million
Q1 2020 May 13, 2020	SELL	$47.79 - $75.63 $222,653 - $352,360	-4,659 Reduced 15.24%	25,908 $6.98 Million
Q4 2019 Feb 04, 2020	BUY	$36.62 - $57.29 $20,324 - $31,795	555 Added 1.85%	30,567 $6.69 Million
Q3 2019 Nov 08, 2019	BUY	$35.53 - $43.8 $82,642 - $101,878	2,326 Added 8.4%	30,012 $4.48 Million
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $6,542 - $9,146	-235 Reduced 0.84%	27,686 $4.15 Million
Q1 2019 May 08, 2019	SELL	$28.07 - $38.18 $240,054 - $326,515	-8,552 Reduced 23.45%	27,921 $3.33 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $35,437 - $49,066	1,313 Added 3.73%	36,473 $4.37 Million
Q3 2018 Nov 01, 2018	SELL	$23.35 - $36.72 $212,064 - $333,491	-9,082 Reduced 20.53%	35,160 $5.03 Million
Q2 2018 Aug 08, 2018	BUY	$17.54 - $25.22 $73,422 - $105,570	4,186 Added 10.45%	44,242 $4.2 Million
Q1 2018 May 08, 2018	BUY	$13.06 - $18.54 $168,996 - $239,907	12,940 Added 47.72%	40,056 $2.97 Million
Q4 2017 Feb 02, 2018	SELL	$11.12 - $15.38 $46,859 - $64,811	-4,214 Reduced 13.45%	27,116 $1.56 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $355,908 - $594,643	31,330	31,330 $1.53 Million

Others Institutions Holding DXCM

# of Institutions

1,043

Shares Held

356M

Call Options Held

5.32M

Put Options Held

5.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account